Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Hetero Labs Limited - Unit III
FDA Inspection
•Hetero Labs Limited - Unit III•June 7, 2019

Hetero Labs Limited - Unit III – FDA Inspection, Jun 7, 2019

Record Details

This FDA Inspection record concerns Hetero Labs Limited - Unit III, with an inspection on June 7, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Hetero Labs Limited - Unit III
Inspection Date
June 7, 2019
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Miguel A. Martinez
  • Rita K. Vick (Issuing Officer)
View Company Profile

ID · 0d583d9c-18e6-405d-afa9-92fe6aab6286

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1092347
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

10
  1. 21 CFR 211.68(b)Computer control of master formula records
  2. 21 CFR 211.194(d)Laboratory equipment calibration records
  3. 21 CFR 211.170(b)Reserve samples identified, representative, stored
  4. 21 CFR 211.170(b)Annual visual exams of drug products
  5. 21 CFR 211.165(a)Testing and release for distribution
  6. 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
  7. 21 CFR 211.100(a)Absence of Written Procedures
  8. 21 CFR 211.192Investigations of discrepancies, failures
  9. 21 CFR 211.22(d)Procedures not in writing, fully followed
  10. 21 CFR 211.100(b)SOPs not followed / documented

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Hetero Labs Limited - Unit III

8
DateClassificationOfficeProject area
July 21, 2023VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
October 26, 2018Not classifiedOffice of Inspections and InvestigationsDrug Quality Assurance
March 23, 2018NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
October 26, 2016VAICenter for Drug Evaluation and ResearchGeneric Drug Evaluation
July 31, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 8 other inspections on the company page
Other documents for Hetero Labs Limited - Unit III
  • FDA Inspection 1210507 - 2023-07-21
  • FDA Inspection 1071009 - 2018-10-26
  • FDA Inspection 1045339 - 2018-03-23
  • FDA Inspection 993030 - 2016-10-26
  • FDA Inspection 940470 - 2015-07-31

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hetero Labs Limited - Unit III
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.